Following an oversubscribed first year, Pfizer Ltd has opened applications to the second cohort of Pfizer Healthcare Hub: London. The initiative, which began in 2017, helps established start-up companies, innovating at the cross-section between health and technology, to grow.
The Pfizer Healthcare Hub: London is a part of a global network of Pfizer innovation hubs, including existing centres in Berlin, Stockholm, Sydney, North America and Tel Aviv.
Innovation in health
Pfizer is seeking to support start-ups who have developed a product or service ready for use by the public or healthcare professionals which can show evidence of benefits to patients or clinicians.
Start-ups will compete for a share of a grant of £50k and a year-long programme of support, helping them to navigate the UK’s health system and giving them the opportunity to meet the people who can move their ideas and their businesses forward. The winners will also benefit from access to Pfizer’s network of partners, including the NHS, seeking to improve the experience and outcomes of patients.
UK-registered companies and charities looking for support are invited to enter the process for a chance to become part of this year’s programme by visiting: healthcarehub.pfizer.co.uk.
Previous winners
The three 2017 UK Hub winners, Cera, Echo and GiveVision, were selected from over 100 applications after a rigorous pitch process at Pfizer’s UK head office and ultimately demonstrated how their technology could deliver real benefits across the health system today.
All three delivered a very different offering: Cera is a technology enabled home care provider, Echo provides a free app that lets you order NHS prescriptions and have medication delivered to your door and GiveVision develop a wearable headset to give the visually impaired improved vision.
